top
Search terms
Results 1 - 10 of 56 - ordered by :
Pages: 1 2 3 4 5 6 ... 6
Escardio

Professor Deepak L. Bhatt (Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA) describes the rationale for the study, which is the largest trial in type 2 ...

Date : 02/09/2019
Escardio

The combination of ticagrelor and aspirin reduces ischaemic events compared with aspirin alone in patients with stable coronary artery disease and diabetes. Senior author Professor Deepak L. Bhatt ...

Date : 01/09/2019
Escardio

Senior author Professor Philippe Gabriel Steg of Hospital Bichat, Paris, France said: “Treatment with ticagrelor and aspirin also increased major bleeding relative to aspirin alone, but there ...

Date : 01/09/2019
Ehjcardiovascrec

The last three decades have seen significant advances in interventional and pharmacologic therapy for coronary artery disease (CAD). COX-1 is completely inhibited in over 99% of patients;1 however, ...

Cardiovascular Research, Friede, Kevin A, Voora, Deepak

Date : 01/08/2019 Item size : 134905 bytes
ESC365

Accelerated accrural of ischaemic events after stopping dual antiplatelet therapy at 12 months in a real-world acute myocardial infarction cohort

Date : 27/08/2018
Ehjournal

Abstract This editorial refers to Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results ...

European Heart Journal, Varenne, Olivier, Sinnaeve, Peter R

Date : 01/08/2018 Item size : 183144 bytes
Ehjournal

Antithrombotic strategies in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are evolving. Oral anticoagulation (OAC) has been shown to be superior to dual ...

European Heart Journal, Hammoudi, Nadjib, Montalescot, Gilles

Date : 14/05/2018 Item size : 126107 bytes
Ehjournal

Antithrombotic strategies in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are evolving. Oral anticoagulation (OAC) has been shown to be superior to dual ...

European Heart Journal, Hammoudi, Nadjib, Montalescot, Gilles

Date : 14/05/2018 Item size : 133020 bytes
Ehjournal

Oral anticoagulation (OAC) has been shown to be superior to dual antiplatelet therapy (DAPT) in preventing stroke in patients with AF, while DAPT has been shown to be superior to OAC in preventing ...

European Heart Journal, Hammoudi, Nadjib, Montalescot, Gilles

Date : 14/05/2018 Item size : 174473 bytes
Ehjournal

Clopidogrel instead of prasugrel or ticagrelor after 1 month in stabilized ACS patients: back to square one for DAPT? Following an acute coronary syndrome (ACS), patients remain at risk for new ...

European Heart Journal, Sinnaeve, Peter R., Van de Werf, Frans

Date : 01/11/2017 Item size : 117056 bytes